IMMUNOACTIVATOR, VACCINE ADJUVANT, AND METHOD FOR INDUCING IMMUNITY

In order to provide an immunoactivator capable of enhancing both humoral immunity and cellular immunity, the active ingredient of the immunoactivator being derived from cell walls (derived from a natural product), to provide a vaccine adjuvant, and to provide a method for inducing immunity, the method having a step for administering the immunoactivator, an immunoactivator according to the present invention has particles having a maximum diameter within the range of 1-800 nm as the active ingredient, the particles being composed of cell-wall-derived polysaccharides..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 02. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

SUZUKI RYO [VerfasserIn]
OMATA DAIKI [VerfasserIn]
MUNAKATA LISA [VerfasserIn]
SUZUKI YUNO [VerfasserIn]
KOIZUMI KEIICHI [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-02, Last update posted on www.tib.eu: 2024-04-17, Last updated: 2024-04-26

Patentnummer:

WO2023210722

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000290378